Zobrazeno 1 - 10
of 405
pro vyhledávání: '"Mm, Horowitz"'
Autor:
E Gluckman, AD Auerbach, MM Horowitz, KA Sobocinski, RC Ash, MM Bortin, A Butturini, BM Camitta, RE Champlin, W Friedrich
Publikováno v:
Blood. 86:2856-2862
Fanconi anemia is a genetic disorder associated with diverse congenital abnormalities, progressive bone marrow failure, and increased risk of leukemia and other cancers. Affected persons often die before 30 years of age. Bone marrow transplantation i
Autor:
WR Drobyski, RC Ash, JT Casper, T McAuliffe, MM Horowitz, C Lawton, C Keever, LA Baxter-Lowe, B Camitta, F Garbrecht
Publikováno v:
Blood. 83:1980-1987
Between January 1988 and March 1993, 48 patients received T-cell- depleted marrow grafts from unrelated donors as treatment for chronic myelogenous leukemia (CML). The median age of the population was 31.7 years (range 5.4 to 53) with 17 of 48 patien
Autor:
MM Horowitz, D Przepiorka, RE Champlin, RP Gale, A Gratwohl, RH Herzig, HG Prentice, AA Rimm, O Ringden, MM Bortin
Publikováno v:
Blood. 79:2771-2774
There is substantial evidence that the volume of medical procedures in a hospital has an inverse relationship with mortality. We analyzed data for 1313 recipients of HLA-identical sibling bone marrow transplants for early leukemia (acute leukemia in
Autor:
Rp, Gale, Hehlmann R, Mj, Zhang, Hasford J, Jm, Goldman, Heimpel H, Hochhaus A, Jp, Klein, Hj, Kolb, Pb, Mcglave, Jakob R Passweg, Pa, Rowlings, Ka, Sobocinski, Mm, Horowitz
Publikováno v:
Europe PubMed Central
Hydroxyurea, interferon, and HLA-identical sibling bone marrow transplantation are common therapies for chronic myelogenous leukemia (CML) in chronic phase. Which is best is controversial. The purpose of this study was to compare survival of patients
Publikováno v:
Europe PubMed Central
The International Bone Marrow Transplant Registry (IBMTR), established in 1972, collects data on recipients of allogeneic bone marrow transplants from over 320 institutions, worldwide. Its database includes information for about 40% of all allogeneic
Autor:
JC Biggs, MM Horowitz, RP Gale, RC Ash, K Atkinson, W Helbig, N Jacobsen, GL Phillips, AA Rimm, O Ringden
Publikováno v:
Blood. 80(4)
About 30% of adults with acute lymphoblastic leukemia (ALL) and 20% to 40% of children and adults with acute myelogenous leukemia (AML) never achieve remission, even with intensive chemotherapy. Most die of resistant leukemia, often within 6 months o
Autor:
AJ Barrett, MM Horowitz, RC Ash, K Atkinson, RP Gale, JM Goldman, PJ Henslee- Downey, RH Herzig, B Speck, FE Zwaan
Publikováno v:
Blood. 79(11)
Philadelphia chromosome (Ph1)-positive acute lymphoblastic leukemia (ALL) has a poor prognosis when treated with conventional chemotherapy. We analyzed the outcome of 67 HLA-identical sibling bone marrow transplants (BMTs) for Ph1-positive ALL report
Autor:
E Gluckman, MM Horowitz, RE Champlin, JM Hows, A Bacigalupo, JC Biggs, BM Camitta, RP Gale, EC Gordon-Smith, AM Marmont
Publikováno v:
Blood. 79(1)
Data for 595 patients with severe aplastic anemia receiving HLA- identical sibling bone marrow transplants were analyzed to determine the effect of pretransplant conditioning and graft-versus-host disease (GVHD) prophylaxis on outcome. Transplants we
Autor:
AM Marmont, MM Horowitz, RP Gale, K Sobocinski, RC Ash, DW van Bekkum, RE Champlin, KA Dicke, JM Goldman, RA Good
Publikováno v:
Blood. 78(8)
We analyzed the effects of T-cell depletion on the outcome of HLA- identical sibling bone marrow transplants for leukemia by comparing 731 T-cell-depleted transplants with 2,480 non-T-cell-depleted transplants. T-cell depletion decreased acute graft-
Autor:
K Atkinson, MM Horowitz, RP Gale, DW van Bekkum, E Gluckman, RA Good, N Jacobsen, HJ Kolb, AA Rimm, O Ringden
Publikováno v:
Blood. 75(12)
Chronic graft-versus-host disease (GVHD) is an important complication of bone marrow transplantation. We analyzed risk factors for chronic GVHD in 2,534 recipients of HLA-identical sibling transplants surviving at least 90 days after transplantation.